How many drugs treat Simple partial seizure?

Drug Landscape tracks 10 marketed treatments for Simple partial seizure (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

What's the most recent regulatory action in Simple partial seizure?

Most recent: Keppra — FDA approved.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/simple-partial-seizure.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Simple partial seizure — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Simple partial seizure (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Simple partial seizure, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Keppra	levetiracetam	Generic (originally UCB Pharma)	Antiepileptic agent	Synaptic vesicle protein SV2A	1999-11-30
Gabitril	TIAGABINE	Cephalon	Anti-epileptic Agent	Sodium- and chloride-dependent GABA transporter 1	1997-01-01
Felbatol	FELBAMATE	Mylan Speciality Lp	Anti-epileptic Agent [EPC]	NMDA receptor-ionophore complex	1993-01-01
Tegretol	carbamazepine	Novartis AG (originally Geigy)	Mood Stabilizer [EPC]	Frizzled-8, Nuclear receptor subfamily 1 group I member 2, Neuronal acetylcholine receptor; alpha2/beta4	1968-03-11
Mysoline	PRIMIDONE	Bausch Health	Anti-epileptic Agent [EPC]	Transient receptor potential cation channel subfamily M member 3	1954-01-01
Phenytoin Sodium	PHENYTOIN	Viatris	Anti-epileptic Agent	Sodium channel protein type 2 subunit alpha	1953-01-01
Dilantin	Phenytoin Sodium	Pfizer	phenytoin	Nuclear receptor subfamily 1 group I member 3	1953-01-01
Topamax	Topamax	Ataturk University		Nuclear receptor subfamily 1 group I member 2, Carbonic anhydrase 1, Carbonic anhydrase 12
Topamax	topiramate	Janssen		Nuclear receptor subfamily 1 group I member 2, Carbonic anhydrase 1, Carbonic anhydrase 12
Lamictal	lamotrigine	GSK	Anti-epileptic Agent [EPC]	5-hydroxytryptamine receptor 3A, Sigma non-opioid intracellular receptor 1, Sodium channel protein type 1 subunit alpha

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

2026-05-08 — Keppra · FDA · approved · US
2026-03-18 — Topamax · FDA · approved · US

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Ataturk University · 1 drug in Simple partial seizure
Bausch Health · 1 drug in Simple partial seizure
Cephalon · 1 drug in Simple partial seizure
Enanta Pharmaceuticals, Inc · 1 drug in Simple partial seizure
GSK · 1 drug in Simple partial seizure
Generic (originally UCB Pharma) · 1 drug in Simple partial seizure
Institute of Child Health · 1 drug in Simple partial seizure
Janssen · 1 drug in Simple partial seizure
Masonic Cancer Center, University of Minnesota · 1 drug in Simple partial seizure
Mylan Speciality Lp · 1 drug in Simple partial seizure
Novartis AG (originally Geigy) · 1 drug in Simple partial seizure
Pfizer · 1 drug in Simple partial seizure

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Simple partial seizure:

Cite this brief

Drug Landscape (2026). Simple partial seizure — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/simple-partial-seizure. Accessed 2026-06-10.

Simple partial seizure full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing